Patients
Biosimilars: Unlocking access, closing the cost divide
… the gap for good There's no shortage of interest in fixing …
214 items found
News
Novo Nordisk unleashes Wegovy telehealth blitz
… drug is no longer on the FDA shortage list. A huge market for …
News
First gene-edited pig liver transplant 'worked for 10 days'
… the problem of a worldwide shortage of human donors. Pigs are …
News
Novo Nordisk follows Lilly into DTC obesity drug market
… in Wegovy – from the FDA's shortage list and comes a few … drugs now officially off the shortage list, the clock has …
News
Lilly uses Oscars ad to warn about 'untested' GLP-1s
… Appearing on the FDA's shortage list opened the door for …
News
AI tool detects brain lesions linked to epilepsy
… the US – in how to use it. Drug shortage problem The potential of …
News
Compounders cast adrift after semaglutide shortage ends
… has said there is no longer a shortage in the US market for Novo … a brandname drug on the FDA shortage list can be made …
R&D
Will 2025 be the year the pharmaceutical industry finds its feet?
… strings. Meanwhile, there is no shortage of great science and …
News
Pharma group slams Hims & Hers over Super Bowl GLP-1 ad
… the drug appears on the FDA's shortage list, which opens the … resort for patients during a shortage and should never be the …
News
Novo rises on Wegovy sales leap, but warns of a slowdown
… constraints and related drug shortage notifications across a …
News
Lilly nets Scorpion cancer drug in $2.5bn licensing deal
… set up Scorpion. There's no shortage of other candidates …
News
Novo Nordisk asks FDA not to allow GLP-1 compounding
… – for example, if there is a shortage in the marketplace. Some …
News
GSK pays $1.2bn for liver drug as it culls TIGIT programme
GSK decided to abandon a TIGIT-targeted drug for cancer this week, then hatched a plan to replace it with a candidate for liver disease MASH.
Market Access
Sponsored
Bridging research and clinical guidelines – interactive stra...
Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
R&D
Deep Dive: Research and Development 2025
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
R&D
Life Sciences Industry Report - Biologics and Generics
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
Market Access
The value of a partner, globally and locally
A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
Oncology
Life Sciences Industry Report - Oncology
Developments in the oncology space in 2024 brought hope to both industry and patients.
Patients
Partner Content
Operationalize: Expanded Access Programs comes to the West C...
Improving Global Access to Life-Changing Therapeutics...
Sales & Marketing
Partner Content
The ESG in Life Sciences Summit is coming to the West Coast!
The ESG in Life Sciences Summit West is coming to San Francisco! (July 8-10, 2025).